COVID-19 Impact on Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, Status and Forecast 2020-2026
- BMR3871625
- 96 Pages
- June 2020
- Healthcare
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Rx Irritable Bowel Syndrome (IBS) Drugs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Rx Irritable Bowel Syndrome (IBS) Drugs industry.
Based on our recent survey, we have several different scenarios about the Rx Irritable Bowel Syndrome (IBS) Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Rx Irritable Bowel Syndrome (IBS) Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Rx Irritable Bowel Syndrome (IBS) Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Rx Irritable Bowel Syndrome (IBS) Drugs market in terms of revenue.
Players, stakeholders, and other participants in the global Rx Irritable Bowel Syndrome (IBS) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Rx Irritable Bowel Syndrome (IBS) Drugs market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Rx Irritable Bowel Syndrome (IBS) Drugs market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Rx Irritable Bowel Syndrome (IBS) Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Rx Irritable Bowel Syndrome (IBS) Drugs market.
The following players are covered in this report:
Ironwood Pharmaceuticals
Bausch Health
Takeda
Sebela Pharmaceuticals
Allergan
...
Rx Irritable Bowel Syndrome (IBS) Drugs Breakdown Data by Type
IBS-D Drugs
IBS-C Drugs
Others
Rx Irritable Bowel Syndrome (IBS) Drugs Breakdown Data by Application
Women
Men
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Rx Irritable Bowel Syndrome (IBS) Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 IBS-D Drugs
1.4.3 IBS-C Drugs
1.4.4 Others
1.5 Market by Application
1.5.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application: 2020 VS 2026
1.5.2 Women
1.5.3 Men
1.6 Coronavirus Disease 2019 (Covid-19): Rx Irritable Bowel Syndrome (IBS) Drugs Industry Impact
1.6.1 How the Covid-19 is Affecting the Rx Irritable Bowel Syndrome (IBS) Drugs Industry
1.6.1.1 Rx Irritable Bowel Syndrome (IBS) Drugs Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Rx Irritable Bowel Syndrome (IBS) Drugs Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Rx Irritable Bowel Syndrome (IBS) Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Rx Irritable Bowel Syndrome (IBS) Drugs Market Perspective (2015-2026)
2.2 Rx Irritable Bowel Syndrome (IBS) Drugs Growth Trends by Regions
2.2.1 Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Rx Irritable Bowel Syndrome (IBS) Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Rx Irritable Bowel Syndrome (IBS) Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Rx Irritable Bowel Syndrome (IBS) Drugs Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Players by Market Size
3.1.1 Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Players by Revenue (2015-2020)
3.1.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Concentration Ratio
3.2.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Rx Irritable Bowel Syndrome (IBS) Drugs Revenue in 2019
3.3 Rx Irritable Bowel Syndrome (IBS) Drugs Key Players Head office and Area Served
3.4 Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Product Solution and Service
3.5 Date of Enter into Rx Irritable Bowel Syndrome (IBS) Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Historic Market Size by Type (2015-2020)
4.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Type (2021-2026)
5 Rx Irritable Bowel Syndrome (IBS) Drugs Breakdown Data by Application (2015-2026)
5.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2015-2020)
5.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2015-2020)
6.2 Rx Irritable Bowel Syndrome (IBS) Drugs Key Players in North America (2019-2020)
6.3 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2015-2020)
6.4 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2015-2020)
7 Europe
7.1 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2015-2020)
7.2 Rx Irritable Bowel Syndrome (IBS) Drugs Key Players in Europe (2019-2020)
7.3 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2015-2020)
7.4 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2015-2020)
8 China
8.1 China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2015-2020)
8.2 Rx Irritable Bowel Syndrome (IBS) Drugs Key Players in China (2019-2020)
8.3 China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2015-2020)
8.4 China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2015-2020)
9 Japan
9.1 Japan Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2015-2020)
9.2 Rx Irritable Bowel Syndrome (IBS) Drugs Key Players in Japan (2019-2020)
9.3 Japan Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2015-2020)
9.4 Japan Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2015-2020)
10.2 Rx Irritable Bowel Syndrome (IBS) Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2015-2020)
11 India
11.1 India Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2015-2020)
11.2 Rx Irritable Bowel Syndrome (IBS) Drugs Key Players in India (2019-2020)
11.3 India Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2015-2020)
11.4 India Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2015-2020)
12.2 Rx Irritable Bowel Syndrome (IBS) Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2015-2020)
12.4 Central & South America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Ironwood Pharmaceuticals
13.1.1 Ironwood Pharmaceuticals Company Details
13.1.2 Ironwood Pharmaceuticals Business Overview and Its Total Revenue
13.1.3 Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Introduction
13.1.4 Ironwood Pharmaceuticals Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2015-2020))
13.1.5 Ironwood Pharmaceuticals Recent Development
13.2 Bausch Health
13.2.1 Bausch Health Company Details
13.2.2 Bausch Health Business Overview and Its Total Revenue
13.2.3 Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Introduction
13.2.4 Bausch Health Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2015-2020)
13.2.5 Bausch Health Recent Development
13.3 Takeda
13.3.1 Takeda Company Details
13.3.2 Takeda Business Overview and Its Total Revenue
13.3.3 Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Introduction
13.3.4 Takeda Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2015-2020)
13.3.5 Takeda Recent Development
13.4 Sebela Pharmaceuticals
13.4.1 Sebela Pharmaceuticals Company Details
13.4.2 Sebela Pharmaceuticals Business Overview and Its Total Revenue
13.4.3 Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Introduction
13.4.4 Sebela Pharmaceuticals Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2015-2020)
13.4.5 Sebela Pharmaceuticals Recent Development
13.5 Allergan
13.5.1 Allergan Company Details
13.5.2 Allergan Business Overview and Its Total Revenue
13.5.3 Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Introduction
13.5.4 Allergan Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2015-2020)
13.5.5 Allergan Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Licenses Type
USD 3,900 Single License
USD 7,800 Enterprise License
BUY NOW Add to Cart
Why QYR
Fastest report delivery service
More than 10 years of vast experience
Operational for 24 * 7 & 365 days
In-depth and comprehensive analysis
Excellent after sales support
Owns large database
Need Help ?
Email Us FAQ
COVID 19 Impact on Global Rx Irritable Bowel Syndrome IBS Drugs market
Table 1. Rx Irritable Bowel Syndrome (IBS) Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Rx Irritable Bowel Syndrome (IBS) Drugs Revenue
Table 3. Ranking of Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of IBS-D Drugs
Table 6. Key Players of IBS-C Drugs
Table 7. Key Players of Others
Table 8. COVID-19 Impact Global Market: (Four Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Rx Irritable Bowel Syndrome (IBS) Drugs Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Rx Irritable Bowel Syndrome (IBS) Drugs Players to Combat Covid-19 Impact
Table 13. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Regions (2015-2020)
Table 17. Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Rx Irritable Bowel Syndrome (IBS) Drugs Market Growth Strategy
Table 23. Main Points Interviewed from Key Rx Irritable Bowel Syndrome (IBS) Drugs Players
Table 24. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Players (2015-2020) (Million US$)
Table 25. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Players (2015-2020)
Table 26. Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs as of 2019)
Table 27. Global Rx Irritable Bowel Syndrome (IBS) Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Product Solution and Service
Table 30. Date of Enter into Rx Irritable Bowel Syndrome (IBS) Drugs Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2015-2020) (Million US$)
Table 33. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Share by Type (2015-2020)
Table 34. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Type (2021-2026)
Table 35. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Share by Application (2015-2020)
Table 36. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2015-2020) (Million US$)
Table 37. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Share by Application (2021-2026)
Table 38. North America Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Market Share (2019-2020)
Table 40. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2015-2020) (Million US$)
Table 41. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2015-2020)
Table 42. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2015-2020) (Million US$)
Table 43. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2015-2020)
Table 44. Europe Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Market Share (2019-2020)
Table 46. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2015-2020)
Table 48. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2015-2020)
Table 50. China Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (2019-2020) (Million US$)
Table 51. China Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Market Share (2019-2020)
Table 52. China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2015-2020) (Million US$)
Table 53. China Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2015-2020)
Table 54. China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2015-2020) (Million US$)
Table 55. China Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2015-2020)
Table 56. Japan Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Market Share (2019-2020)
Table 58. Japan Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2015-2020)
Table 60. Japan Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Market Share (2019-2020)
Table 64. Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2015-2020)
Table 66. Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2015-2020)
Table 68. India Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (2019-2020) (Million US$)
Table 69. India Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Market Share (2019-2020)
Table 70. India Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2015-2020) (Million US$)
Table 71. India Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2015-2020)
Table 72. India Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2015-2020) (Million US$)
Table 73. India Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Market Share (2019-2020)
Table 76. Central & South America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2015-2020)
Table 78. Central & South America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2015-2020)
Table 80. Ironwood Pharmaceuticals Company Details
Table 81. Ironwood Pharmaceuticals Business Overview
Table 82. Ironwood Pharmaceuticals Product
Table 83. Ironwood Pharmaceuticals Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2015-2020) (Million US$)
Table 84. Ironwood Pharmaceuticals Recent Development
Table 85. Bausch Health Company Details
Table 86. Bausch Health Business Overview
Table 87. Bausch Health Product
Table 88. Bausch Health Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2015-2020) (Million US$)
Table 89. Bausch Health Recent Development
Table 90. Takeda Company Details
Table 91. Takeda Business Overview
Table 92. Takeda Product
Table 93. Takeda Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2015-2020) (Million US$)
Table 94. Takeda Recent Development
Table 95. Sebela Pharmaceuticals Company Details
Table 96. Sebela Pharmaceuticals Business Overview
Table 97. Sebela Pharmaceuticals Product
Table 98. Sebela Pharmaceuticals Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2015-2020) (Million US$)
Table 99. Sebela Pharmaceuticals Recent Development
Table 100. Allergan Company Details
Table 101. Allergan Business Overview
Table 102. Allergan Product
Table 103. Allergan Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2015-2020) (Million US$)
Table 104. Allergan Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type: 2020 VS 2026
Figure 2. IBS-D Drugs Features
Figure 3. IBS-C Drugs Features
Figure 4. Others Features
Figure 5. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application: 2020 VS 2026
Figure 6. Women Case Studies
Figure 7. Men Case Studies
Figure 8. Rx Irritable Bowel Syndrome (IBS) Drugs Report Years Considered
Figure 9. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Regions: 2020 VS 2026
Figure 11. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Players in 2019
Figure 14. Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Rx Irritable Bowel Syndrome (IBS) Drugs Revenue in 2019
Figure 16. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Ironwood Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Ironwood Pharmaceuticals Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2015-2020)
Figure 25. Bausch Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Bausch Health Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2015-2020)
Figure 27. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Takeda Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2015-2020)
Figure 29. Sebela Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Sebela Pharmaceuticals Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2015-2020)
Figure 31. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Allergan Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2015-2020)
Figure 33. Bottom-up and Top-down Approaches for This Report
Figure 34. Data Triangulation
Figure 35. Key Executives Interviewed
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
